The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Guides/Reports
The UDI-DI Change Communication Process Work Group, a part of AHRMM's Learning UDI Community (LUC), recently released a report analyzing current…
The UDI Impacts on Recall Management Work Group, a part of AHRMM's Learning UDI Community (LUC), has released their recommended practices reports…
White Papers
Consider how direct sourcing can enable access to PPE and the leading practices of building supply chain diversity and resiliency for the future in…
Guides/Reports
Though the health care industry is continuing to tackle the COVID-19 pandemic, many industry leaders are also looking to build a more resilient sup
White Papers
Healthcare expenses continue to rise and yet hospitals are realizing consistently shrinking margins.
AHRMM What's New
Begin the year with a fresh organizational outlook using AHRMM’s Policies and Procedures Manual for the Health Care Supply Chain, 2nd Edition.…